HAIZHI TECH GP (02706) Enters into a Strategic Cooperation Framework Agreement with Jointown Pharmaceutical Group to Carry Out Strategic Cooperation Around the Digital and Intelligent Transformation of the Pharmaceutical Distribution Industry

HAIZHI TECH GP (02706) announces that the Company recently entered into a strategic cooperation framework agreement (the "Strategic Cooperation Framework Agreement") with Jointown Pharmaceutical Group Co., Ltd. ("Jointown Pharmaceutical Group"). Pursuant to the Strategic Cooperation Framework Agreement, the Company and Jointown Pharmaceutical Group will carry out strategic cooperation around the digital and intelligent transformation of the pharmaceutical distribution industry, including but not limited to using Atlas graph solutions and Atlas intelligent agents as carriers, leveraging multi-modal databases and ontology technology to build a two-tier empowerment architecture of "data and business semantic foundationintelligent agent applications," providing intelligent decision support for Jointown Pharmaceutical Group's supply chain business; and jointly innovating typical industry AI applications, compiling frontline business knowledge into reusable ontology models and skill libraries, and creating and promoting benchmark digital and intelligent solutions for the pharmaceutical distribution industry. The Company focuses on developing Atlas graph solutions and Atlas intelligent agents through graph-model fusion technology, and provides industry-grade artificial intelligence solutions. Jointown Pharmaceutical Group is a leading domestic pharmaceutical distribution industry group, whose A-shares are listed on the Shanghai Stock Exchange (stock code: 600998). Jointown Pharmaceutical Group has a nationwide distribution, logistics, and terminal service network, and possesses deep business accumulation across the entire distribution chain, including procurement, inventory, warehousing, transportation, orders, quality management, finance, and customer operations. The board of directors of the Company believes that, by leveraging the respective technological advantages, industry experience, and market resources of both parties, the strategic cooperation contemplated under the Strategic Cooperation Framework Agreement will achieve resource complementarity and collaborative development, facilitating the digital and intelligent transformation (i.e., AI-driven upgrading) of the pharmaceutical distribution industry.